A preliminary study published in Nature reveals that COVID-19 vaccines may enhance the immune system, making immunotherapy more effective against cancer.
The study, titled "SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade," was led by Adam J. Grippin and corresponding author Steven Lin.
The study suggests that COVID-19 vaccines might boost the immune system to make immunotherapy more effective.
This potential breakthrough is a positive development amidst concerns about the impact of current health policies on federal public health institutions, including the National Institutes of Health and the Centers for Disease Control and Prevention.
Author's summary: COVID-19 vaccines may improve cancer treatment.